Cargando…
Gonadotropin Suppression for 7 Years After a Single Histrelin Implant for Precocious Puberty
Gonadotropin-releasing hormone analogues (GnRHas) are an effective treatment to address the compromise in height potential seen in patients with central precocious puberty. There is no evidence in the literature of a single GnRHa used for longer than 2 years before being removed or replaced. We desc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758400/ https://www.ncbi.nlm.nih.gov/pubmed/35047716 http://dx.doi.org/10.1210/jendso/bvab189 |